Antiintegrin drug treatments in numerous studies regarding inflamation related colon condition IBD observations straight into promising providers: Revision history

Jump to: navigation, search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

25 January 2024

  • curprev 13:3413:34, 25 January 2024‎ Mathsphynx8 talk contribs‎ 3,701 bytes +3,701‎ Created page with "37/864 [4.3%]; Further ed Three quarter's, 3.Thirty three; 95% CI, 3.19-0.57; RE Three quarter, 3.Thirty-seven; 95% CI, 0.21-0.66). Thromboprophylaxis has not been linked to greater probability of hematoma development or perhaps rebleeding (32/1,319 [2.4%] versus. 37/1,301 [2.8%]; FE Three quarter, 3.70; 95% CI, 3.48-1.20; Lso are Three quarter's, 2.Eighty; 95% CI, 0.49-1.25) or even death (117/925 [12.6%] vs. 139/904 [15.4%]; Further ed RR, 0.Eighty two; 95% CI, 2.65-1...."
Retrieved from "https://news.npo.digital/index.php?title=Antiintegrin_drug_treatments_in_numerous_studies_regarding_inflamation_related_colon_condition_IBD_observations_straight_into_promising_providers"